Crystalline and amorphous forms of beta-L-2'-deoxythymidine
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 28, 2010
Issued Date -
N/A
app pub date -
Jul 20, 2009
filing date -
Aug 6, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Physical forms of beta-L-2'-deoxythymidine are disclosed that can be characterized by physical appearance, purity levels, Infra-Red and Raman spectroscopy, X-ray powder diffraction patterns, thermal properties, and methods of manufacture. These forms of beta-L-2'-deoxythymidine can be used in the manufacture of other forms of beta-L-2'-deoxythymidine, or in pharmaceutical compositions. Particularly preferred uses are in the treatment of hepatitis B.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully